drugset / Trial / NCT05373303
The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®
RandomizedParallel-groupOpen-labelTreatment
Summary
The study was conducted to evaluate whether the efficacy and safety profile of recombinant human erythropoietin (rhEPO) manufactured by Daewoong Pharmaceutical Co., Ltd was similar to biological products approved by the drug safety regulatory authority.
Timeline
- Start
- 2019-11-07
- Primary completion
- 2021-05-15
- Completion
- 2022-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Recombinant Human Erythropoietin Alpha | Protein / enzyme biologic | 50 iu/kg | Intravenous |